Page 107 - TD-4-2

Tumor Discovery Cell-cell communication in cancer

doi: 10.3389/fcell.2018.00018 33. Horne J, Mansur S, Bao Y. Sodium ion channels as potential
therapeutic targets for cancer metastasis. Drug Discov Today.
26. Liu SL, Sun P, Li Y, Liu SS, Lu Y. Exosomes as critical
mediators of cell-to-cell communication in cancer 2021;26(5):1136-1147.
pathogenesis and their potential clinical application. Transl doi: 10.1016/j.drudis.2021.01.026
Cancer Res. 2019;8(1):298-311.
34. Rahrmann EP, Shorthouse D, Jassim A, et al. The NALCN
doi: 10.21037/tcr.2019.01.03 channel regulates metastasis and nonmalignant cell
27. Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. dissemination. Nat Genet. 2022;54(12):1827-1838.
Molecular principles of metastasis: A hallmark of cancer doi: 10.1038/s41588-022-01182-0
revisited. Signal Transduct Target Ther. 2020;5:28.
35. Emancipator K. Keytruda and PD-L1: A real-world example
doi: 10.1038/s41392-020-0134-x of co-development of a drug with a predictive biomarker.
28. Aizaz M, Khan A, Khan F, et al. The cross-talk between AAPS J. 2020;23(1):5.
macrophages and tumor cells as a target for cancer treatment. doi: 10.1208/s12248-020-00525-1
Front Oncol. 2023;13:1259034.
36. Abad-Sazatornil MR, Arenaza A, Bayo J, et al. Impact of the
doi: 10.3389/fonc.2023.1259034 subcutaneous formulations of trastuzumab and rituximab
29. Vesely MD, Schreiber RD. Cancer immunoediting: Antigens, on efficiency and resource optimization in Spanish
mechanisms and implications to cancer immunotherapy. Hospitals: H-Excelencia study. BMC Health Serv Res. 2021;
Ann N Y Acad Sci. 2013;1284(1):1-5. 21(1):320.
doi: 10.1111/nyas.12105 doi: 10.1186/s12913-021-06277-8
30. Nasr MM, Lynch CC. How circulating tumor cluster biology 37. Sterner RC, Sterner RM. CAR-T cell therapy: Current
contributes to the metastatic cascade: From invasion to limitations and potential strategies. Blood Cancer J.
dissemination and dormancy. Cancer Metastasis Rev. 2021;11(4):69.
2023;42(4):1133-1146. doi: 10.1038/s41408-021-00459-7
doi: 10.1007/s10555-023-10124-z 38. Waters EA, McNeel TS, Stevens WM, Freedman AN. Use of
31. Schuster E, Taftaf R, Reduzzi C, Albert MK, Romero-Calvo tamoxifen and raloxifene for breast cancer chemoprevention
I, Liu H. Better together: Circulating tumor cell clustering in in 2010. Breast Cancer Res Treat. 2012;134(2):875-880.
metastatic cancer. Trends Cancer. 2021;7(11):1020-1032. doi: 10.1007/s10549-012-2089-2
doi: 10.1016/j.trecan.2021.07.001 39. Sini V, Botticelli A, Lunardi G, Gori S, Marchetti P.
32. Bouchalova P, Bouchal P. Current methods for studying Pharmacogenetics and aromatase inhibitor induced side
metastatic potential of tumor cells. Cancer Cell Int. effects in breast cancer patients. Pharmacogenomics.
2022;22:394. 2017;18(8):821-830.
doi: 10.1186/s12935-022-02801-w doi: 10.2217/pgs-2017-0006

Volume 4 Issue 2 (2025) 99 doi: 10.36922/td.8323